NCT05464173 2024-01-22
CINDERELLA
Fudan University
Phase 1/2 Unknown
Clinical Trials
10 trialsBreast Neoplasms × N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide × Clear all
NCT04465097 2023-10-17
NeoTEE
First Affiliated Hospital, Sun Yat-Sen University
Phase 2 Completed
NCT05749575 2023-03-01
Chidamide Plus PD-1 Plus Paclitaxel of Neoadjuvant Treatment in Low HR Expression,HER2-negative Early Breast Cancer.
Sun Yat-sen University
Phase 2 Unknown
NCT05747313 2023-02-28
Chidamide in Combination With Vincristine Metronomic Chemotherapy for Advanced Triple-negative Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1/2 Unknown
NCT05411380 2022-11-04
Tucidinostat Combined With Metronomic Capecitabine and Endocrine Therapy for Advanced HR-positive, HER2-negative Breast Cancer After CDK4/6 Inhibitor.
Sun Yat-sen University
Phase 2 Unknown
NCT05186545 2022-09-02
An Exploratory Study of Surufatinib Combined With Chidamide and Fulvestrant in HR Positive Unresectable Metastatic Breast Cancer
The First Affiliated Hospital of Zhengzhou University
Phase 2 Unknown
NCT05400993 2022-06-06
Clinical Study of Chidamide Combined With Chemotherapy in Neoadjuvant Treatment of HR+/ HER2-BC
Shengjing Hospital
Phase 2 Unknown
NCT05276713 2022-03-11
Outcome of Tucidinostat-Based Therapy in HR+ Metastatic Breast Cancer Patients Previously Treated With CDK4/6 Inhibitor
Beijing 302 Hospital
Unknown
NCT02482753 2022-01-12
Trial of Chidamide in Combination With Exemestane in Patients With Advanced Breast Cancer
Chipscreen Biosciences, Ltd.
Phase 3 Completed
NCT04999540 2021-08-11
Tucidinostat and Fulvestrant in Hormone-receptor Positive Advanced Breast Cancer
Guangdong Women and Children Hospital
Phase 2 Unknown